Loading organizations...
§ Venture Capital · Luxembourg, Luxembourg, Luxembourg
Venture capital firm investing in European life science startups, focusing on drug discovery and medical devices.
Key people at i&i Biotech Fund.
i&i Biotech Fund is an early-stage venture capital firm based in Prague, Czech Republic, investing in European life science academic spinoffs focused on drug discovery, diagnostics, and medical devices. The fund targets unmet medical needs, accelerating proof-of-concept projects by bridging science and business within the ecosystem of IOCB Prague. With a fund size exceeding €53 million, it has deployed capital into at least five portfolio companies, including Dracen Pharmaceuticals, Celeris Therapeutics, and Nanoligent. Key investors include the European Investment Fund (EIF), i&i Prague, and Charles University Innovation Prague. The firm partners with founding partners Karel Kubias, Ivan Vohlmuth, and Tomáš Maršálek to commercialize research from Central European institutions. i&i Biotech Fund was established in 2021 by Jaromír Zahrádka.
Key people at i&i Biotech Fund.
i&i Biotech Fund has 3 tracked investments across 3 companies. The latest tracked deal is $473.0M Seed in Ternary Therapeutics in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 18, 2026 | Ternary Therapeutics | $473.0M Seed | Daphni | Pace Ventures, UK Innovation & Science Seed Fund |
| Mar 3, 2026 | Antiverse | $9.3M Series A | Michal Sikyta | Rhian Elston, Domino Ventures, Lynda Stoelker, Kadmos Capital |
| Dec 17, 2025 | T-Curx | $20.0M Curx - Series A | DR. Aristotelis Nastos | Monika Steger |